Improved dosimetric and clinical outcomes with intensity-modulated radiotherapy for head-and-neck cancer of unknown primary origin

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 3, 2011, Pages 756-762

  Chen, Allen M ^a   Li, Bao Qing ^a   Farwell, D Gregory ^a   Marsano, Joseph ^a   Vijayakumar, Srinivasan ^a   Purdy, James A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cervical lymph node metastasis; Head and neck cancer; Intensity modulated radiotherapy; Toxicity; Unknown primary

Indexed keywords

AFTER-TREATMENT; CERVICAL LYMPH NODES; CLINICAL OUTCOME; CONCURRENT CHEMOTHERAPY; DISEASE-SPECIFIC SURVIVALS; HEAD-AND-NECK CANCER; INTENSITY-MODULATED RADIOTHERAPY; MEAN DOSE; MEDICAL RECORD; MIDDLE EARS; OVERALL SURVIVAL; PAROTID GLANDS; PATIENT POPULATION; QUALITY-OF-LIFE; RADIATION THERAPY; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECKS; UNKNOWN PRIMARY; XEROSTOMIA;

BODY FLUIDS; CHEMOTHERAPY; DISEASE CONTROL; DISEASES; DOSIMETERS; DOSIMETRY; FLUORESCENT SCREENS; PATHOLOGY; PATIENT MONITORING; RADIOTHERAPY; TOXICITY;

PHYSICAL THERAPY;

ADULT; ARTICLE; BRAIN STEM; CANCER OF UNKNOWN PRIMARY SITE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CERVICAL LYMPH NODE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOSIMETRY; DYSPHAGIA; ESOPHAGITIS; ESOPHAGUS STRICTURE; FEEDING APPARATUS; FEMALE; HEAD AND NECK CARCINOMA; HOARSENESS; HUMAN; INNER EAR; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LARYNX EDEMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE EAR; OTITIS MEDIA; OVERALL SURVIVAL; PRIORITY JOURNAL; QUALITY OF LIFE; SKIN EXFOLIATION; SPINAL CORD; SQUAMOUS CELL CARCINOMA; TEMPORAL LOBE; TREATMENT OUTCOME; TREATMENT PLANNING; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DISEASE-FREE SURVIVAL; EAR, INNER; EAR, MIDDLE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; NEOPLASMS, UNKNOWN PRIMARY; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; XEROSTOMIA;

EID: 79551469123     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.11.020     Document Type: Article

References (27)

1. C. Grau, L.V. Johansen, and J. Jakobsen Cervical lymph node metastases from unknown primary tumours: Results from a national survey by the Danish Society for Head and Neck Oncology Radiother Oncol 55 2000 121 129
2. K. Sinnathamby, L.J. Peters, and C. Laidlaw The occult head and neck primary: To treat or not to treat? Clin Oncol 9 1997 322 329
3. J.L. Lefebvre, B. Coche-Dequeant, and J.T. Van Cervical lymph nodes from an unknown primary tumor in 190 patients Am J Surg 160 1990 443 446
4. P. Strojan, and A. Anicin Combined surgery and postoperative radiotherapy for cervical lymph node metastases from an unknown primary tumor Radiother Oncol 49 1998 33 40
5. S. Ignaej, R. Kagan, and P. Anderson Metastatic squamous cell carcinoma of the neck from an unknown primary: Management options and patterns of relapse Head Neck 24 2002 236 246
6. H. Lu, M. Yao, and H. Tan Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: To what extent the volume should be irradiated Oral Oncol 45 2009 474 479
7. M. Feng, and A. Eisbruch Future issues in highly conformal radiotherapy for head and neck cancer J Clin Oncol 25 2007 1009 1013
8. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
9. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 547 581
10. N. Lee, P. Xia, and N.J. Fischbein Intensity-modulated radiation therapy for head and neck cancer: The UCSF experience focusing on target volume delineation Int J Radiat Oncol Biol Phys 57 2003 49 60
11. G.O. Schoenfeld, R.J. Amdur, and C.G. Morris Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer Int J Radiat Oncol Biol Phys 71 2008 377 385
12. K.S.C. Chao, G. Ozyigit, and B.N. Tran Patterns of failure in patients receiving definitive and postoperative IMRT for head and neck cancer Int J Radiat Oncol Biol Phys 55 2003 312 321
13. A. Eisbruch Reducing xerostomia by IMRT: What may, and may not, be achieved J Clin Oncol 25 2007 4863 4864
14. S. Bhide, C. Clark, and K. Harrington Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site Med Dosim 32 2007 188 195
15. A. Eisbruch, R.K. Ten Haken, and H.M. Kim Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer Int J Radiat Oncol Biol Phys 45 1999 577 587
16. S. Jabbari, H.M. Kim, and M. Feng Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head and neck cancer of unknown primary: Toxicity and preliminary efficiency Int J Radiat Oncol Biol Phys 70 2008 1100 1107
17. M.R. Vergeer, P.A. Doornaert, and D.H. Rietveld Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: Results of a nonrandomized prospective study using a standardized follow-up program Int J Radiat Oncol Biol Phys 74 2009 1 8
18. R. Scrimger, A. Kangi, and M. Parliament Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy Am J Clin Oncol 30 2007 271 277
19. M.K. Kam, S.F. Leung, and B. Zee Prospective randomized study of inensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients J Clin Oncol 25 2007 4873 4879
20. D.L. Kwong, W.I. Wei, and J.S. Sham Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: A prospective study of the effect of radiation and cisplatin treatment Int J Radiat Oncol Biol Phys 36 1996 281 289
21. C.C. Pan, A. Eisbruch, and J.S. Lee Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients Int J Radiat Oncol Biol Phys 61 2005 1393 1402
22. D.I. Rosenthal, M.S. Chambers, and C.D. Fuller Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer Int J Radiat Oncol Biol Phys 72 2008 747 755
23. P.C. Levendag, D.N. Teguh, and P. Voet Dysphagia disorders with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship Radiother Oncol 85 2007 64 73
24. F.Y. Feng, H.M. Kim, and T.H. Lyden Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: Early dose-effect relationships for the swallowing structures Int J Radiat Oncol Biol Phys 68 2007 1289 1298
25. I. Madani, L. Vakaet, and K. Bonte Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer Int J Radiat Oncol Biol Phys 71 2008 1158 1166
26. M.L. Klem, J.G. Mechalakos, and S.L. Wolden Intensity-modulated radiotherapy for head and neck cancer of unknown primary: Toxicity and preliminary efficacy Int J Radiat Oncol Biol Phys 70 2008 1100 1107
27. C. Nieder, V. Gregoire, and K.K. Ang Cervical lymph node metastases from occult squamous cell carcinoma: Cut down a tree to get an apple? Int J Radiat Oncol Biol Phys 50 2001 727 733